Correlation Between DiaMedica Therapeutics and Tourmaline Bio
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Tourmaline Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Tourmaline Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Tourmaline Bio, you can compare the effects of market volatilities on DiaMedica Therapeutics and Tourmaline Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Tourmaline Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Tourmaline Bio.
Diversification Opportunities for DiaMedica Therapeutics and Tourmaline Bio
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between DiaMedica and Tourmaline is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Tourmaline Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tourmaline Bio and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Tourmaline Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tourmaline Bio has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Tourmaline Bio go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Tourmaline Bio
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.09 times more return on investment than Tourmaline Bio. However, DiaMedica Therapeutics is 1.09 times more volatile than Tourmaline Bio. It trades about 0.29 of its potential returns per unit of risk. Tourmaline Bio is currently generating about -0.14 per unit of risk. If you would invest 431.00 in DiaMedica Therapeutics on September 13, 2024 and sell it today you would earn a total of 135.00 from holding DiaMedica Therapeutics or generate 31.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Tourmaline Bio
Performance |
Timeline |
DiaMedica Therapeutics |
Tourmaline Bio |
DiaMedica Therapeutics and Tourmaline Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Tourmaline Bio
The main advantage of trading using opposite DiaMedica Therapeutics and Tourmaline Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Tourmaline Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will offset losses from the drop in Tourmaline Bio's long position.DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Tourmaline Bio vs. Brunswick | Tourmaline Bio vs. Visteon Corp | Tourmaline Bio vs. Li Auto | Tourmaline Bio vs. Precision Drilling |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |